NZ210501A
(en)
|
1983-12-13 |
1991-08-27 |
Kirin Amgen Inc |
Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
|
US4703008A
(en)
|
1983-12-13 |
1987-10-27 |
Kiren-Amgen, Inc. |
DNA sequences encoding erythropoietin
|
KR850004274A
(ko)
|
1983-12-13 |
1985-07-11 |
원본미기재 |
에리트로포이에틴의 제조방법
|
US7217689B1
(en)
|
1989-10-13 |
2007-05-15 |
Amgen Inc. |
Glycosylation analogs of erythropoietin
|
KR100221066B1
(ko)
|
1989-10-13 |
1999-10-01 |
스튜어트 엘.왓트 |
에리트로포이에틴 유사체와 그를 포함하는 제약학적 조성물
|
US5856298A
(en)
|
1989-10-13 |
1999-01-05 |
Amgen Inc. |
Erythropoietin isoforms
|
ZA946122B
(en)
|
1993-08-17 |
1995-03-20 |
Amgen Inc |
Erythropoietin analogs
|
US6562596B1
(en)
|
1993-10-06 |
2003-05-13 |
Amgen Inc. |
Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
|
US5830851A
(en)
|
1993-11-19 |
1998-11-03 |
Affymax Technologies N.V. |
Methods of administering peptides that bind to the erythropoietin receptor
|
US5773569A
(en)
|
1993-11-19 |
1998-06-30 |
Affymax Technologies N.V. |
Compounds and peptides that bind to the erythropoietin receptor
|
US5885574A
(en)
|
1994-07-26 |
1999-03-23 |
Amgen Inc. |
Antibodies which activate an erythropoietin receptor
|
WO1996004925A1
(fr)
|
1994-08-12 |
1996-02-22 |
Immunomedics, Inc. |
Immunoconjugues et anticorps de type humain specifiques contre des lymphomes malins a cellules b et des cellules leucemiques
|
US5686292A
(en)
|
1995-06-02 |
1997-11-11 |
Genentech, Inc. |
Hepatocyte growth factor receptor antagonist antibodies and uses thereof
|
US5767078A
(en)
|
1995-06-07 |
1998-06-16 |
Johnson; Dana L. |
Agonist peptide dimers
|
BR9812267B1
(pt)
|
1997-07-14 |
2013-11-26 |
|
Hormônio de crescimento recombinante.
|
US6753165B1
(en)
|
1999-01-14 |
2004-06-22 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
PT986644E
(pt)
|
1997-07-23 |
2007-01-31 |
Roche Diagnostics Gmbh |
Preparação de eritropoietina por activação genética endógena com promotores virais
|
US6030086A
(en)
|
1998-03-02 |
2000-02-29 |
Becton, Dickinson And Company |
Flash tube reflector with arc guide
|
US6310078B1
(en)
|
1998-04-20 |
2001-10-30 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted amino acids as erythropoietin mimetics
|
US20050181482A1
(en)
|
2004-02-12 |
2005-08-18 |
Meade Harry M. |
Method for the production of an erythropoietin analog-human IgG fusion proteins in transgenic mammal milk
|
DK1088084T3
(da)
|
1998-06-15 |
2007-01-29 |
Gtc Biotherapeutics Inc |
Erythropoietin analog-humant serumalbumin fusionsprotein
|
AR020848A1
(es)
|
1998-10-23 |
2002-05-29 |
Amgen Inc |
Metodos y composiciones para la prevencion y el tratamiento de anemia
|
CN1810832B
(zh)
|
1998-10-23 |
2012-12-12 |
麒麟-安姆根有限公司 |
与MPl受体结合并具有血小板生成活性的模拟二聚体血小板生成素肽
|
CA2352532C
(fr)
|
1998-11-27 |
2014-10-14 |
Darwin Discovery Ltd. |
Compositions et methodes d'augmentation de la mineralisation de la substance osseuse
|
EP1006184A1
(fr)
|
1998-12-03 |
2000-06-07 |
F. Hoffmann-La Roche Ag |
Protéines interagissant avec le récepteur de IGF-1, gènes codant pour ces protéines et leurs utilisations
|
WO2000061637A1
(fr)
|
1999-04-14 |
2000-10-19 |
Smithkline Beecham Corporation |
Anticorps du recepteur d'erythropoietine
|
US7297680B2
(en)
|
1999-04-15 |
2007-11-20 |
Crucell Holland B.V. |
Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
|
CZ299516B6
(cs)
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
CA2388617A1
(fr)
|
1999-10-22 |
2001-05-03 |
Millennium Pharmaceuticals, Inc. |
Molecules d'acide nucleique derivees d'un cerveau de rat et modeles de mort cellulaire programmee
|
CA2391080A1
(fr)
|
1999-11-12 |
2001-05-25 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Formes d'erythropoietine dotees de proprietes ameliorees
|
US20050202538A1
(en)
|
1999-11-12 |
2005-09-15 |
Merck Patent Gmbh |
Fc-erythropoietin fusion protein with improved pharmacokinetics
|
US7223593B2
(en)
|
2000-01-21 |
2007-05-29 |
Biovex Limited |
Herpes virus strains for gene therapy
|
AUPQ599700A0
(en)
|
2000-03-03 |
2000-03-23 |
Super Internet Site System Pty Ltd |
On-line geographical directory
|
US6586398B1
(en)
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
PT1274728E
(pt)
|
2000-04-21 |
2008-06-20 |
Amgen Inc |
Métodos e composições para a prevenção e tratamento de anemia
|
US6756480B2
(en)
|
2000-04-27 |
2004-06-29 |
Amgen Inc. |
Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
|
US7078376B1
(en)
|
2000-08-11 |
2006-07-18 |
Baxter Healthcare S.A. |
Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects
|
AU2001273388B2
(en)
|
2000-09-08 |
2005-01-13 |
Gryphon Therapeutics, Inc. |
"Pseudo"-native chemical ligation
|
US7271689B1
(en)
|
2000-11-22 |
2007-09-18 |
Fonar Corporation |
Magnet structure
|
WO2002049673A2
(fr)
|
2000-12-20 |
2002-06-27 |
F. Hoffmann-La Roche Ag |
Conjugues d'erythropoietine
|
EP2275446A3
(fr)
|
2001-01-05 |
2012-08-15 |
Pfizer Inc. |
Anticorps contre le récepteur I de facteur de croissance de type insuline
|
KR20040032094A
(ko)
|
2001-04-04 |
2004-04-14 |
젠오디세 |
에리트로포이에틴 유전자의 신규한 폴리뉴클레오티드 및폴리펩티드
|
ES2387546T3
(es)
|
2001-05-11 |
2012-09-25 |
Amgen Inc. |
Péptidos y moléculas relacionadas que se unen a TALL-1
|
EP2087908B1
(fr)
|
2001-06-26 |
2018-05-30 |
Amgen Inc. |
Anticorps opgl
|
US6900292B2
(en)
|
2001-08-17 |
2005-05-31 |
Lee-Hwei K. Sun |
Fc fusion proteins of human erythropoietin with increased biological activities
|
CA2456648C
(fr)
|
2001-08-23 |
2011-08-16 |
Genmab A/S |
Anticorps humains specifiques diriges contre l'interleukine 15 (il-15)
|
US7247304B2
(en)
|
2001-08-23 |
2007-07-24 |
Genmab A/S |
Methods of treating using anti-IL-15 antibodies
|
US6930086B2
(en)
|
2001-09-25 |
2005-08-16 |
Hoffmann-La Roche Inc. |
Diglycosylated erythropoietin
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
WO2003055526A2
(fr)
|
2001-12-21 |
2003-07-10 |
Maxygen Aps |
Conjugues d'erythropoietine
|
US7241444B2
(en)
|
2002-01-18 |
2007-07-10 |
Pierre Fabre Medicament |
Anti-IGF-IR antibodies and uses thereof
|
EP1798242B1
(fr)
|
2002-01-18 |
2013-01-23 |
Pierre Fabre Medicament |
Anticorps anti-IGF-IR et leurs applications
|
WO2003064664A1
(fr)
|
2002-01-31 |
2003-08-07 |
Oxford Biomedica (Uk) Limited |
Vecteur d'expression de l'erythropoietine physiologiquement regule, destine au traitement de l'anemie
|
GB0202252D0
(en)
|
2002-01-31 |
2002-03-20 |
Oxford Biomedica Ltd |
Anemia
|
WO2003080852A1
(fr)
|
2002-03-26 |
2003-10-02 |
Lek Pharmaceutical And Chemical Company D.D. |
Procede de preparation du profil de glyco-isoformesd'erythropoietine recherche
|
AU2003222069A1
(en)
|
2002-03-29 |
2003-10-20 |
Centocor, Inc. |
Mammalian cdr mimetibodies, compositions, methods and uses
|
CN101565708B
(zh)
|
2002-03-29 |
2011-09-21 |
组合化学工业株式会社 |
编码乙酰乳酸合酶的基因
|
US20040009902A1
(en)
|
2002-05-13 |
2004-01-15 |
Irving Boime |
CTP extended erythropoietin
|
KR101086533B1
(ko)
|
2002-05-24 |
2011-11-23 |
쉐링 코포레이션 |
중화 사람 항-igfr 항체, 이를 제조하는 방법 및 이를 포함하는 조성물
|
WO2003103750A1
(fr)
*
|
2002-06-05 |
2003-12-18 |
Elan Pharma International Limited |
Adaptateur pour injecteur et sa combinaison
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
US8034904B2
(en)
|
2002-06-14 |
2011-10-11 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
EP1545608A4
(fr)
|
2002-06-28 |
2006-09-13 |
Centocor Inc |
Corps mimetiques mammaliens a deletion ch1, compositions, procedes et utilisations
|
CA2490411A1
(fr)
|
2002-06-28 |
2004-01-08 |
Centocor, Inc. |
Corps mimetiques d'epo de mammifere a deletion ch1, compositions, methodes et utilisations associees
|
AU2003246486A1
(en)
|
2002-07-19 |
2004-02-09 |
Cangene Corporation |
Pegylated erythropoietic compounds
|
WO2004018667A1
(fr)
|
2002-08-26 |
2004-03-04 |
Kirin Beer Kabushiki Kaisha |
Peptides et medicaments les contenant
|
CA2497884C
(fr)
|
2002-09-06 |
2013-10-22 |
Brian Varnum |
Anticorps monoclonal therapeutique anti-il-1r1 humain
|
WO2005025606A1
(fr)
|
2003-09-09 |
2005-03-24 |
Warren Pharmaceuticals, Inc. |
Erythropoietines a action prolongee pouvant maintenir une activite de protection tissulaire d'une erythropoietine endogene
|
CA2496317C
(fr)
|
2002-09-11 |
2014-02-18 |
Fresenius Kabi Deutschland Gmbh |
Procede de production de derives d'amidon hydroxyalkyle
|
US6919426B2
(en)
|
2002-09-19 |
2005-07-19 |
Amgen Inc. |
Peptides and related molecules that modulate nerve growth factor activity
|
US7396913B2
(en)
|
2002-10-14 |
2008-07-08 |
Abbott Laboratories |
Erythropoietin receptor binding antibodies
|
TWI320716B
(en)
|
2002-10-14 |
2010-02-21 |
Abbott Lab |
Erythropoietin receptor binding antibodies
|
US20040071694A1
(en)
|
2002-10-14 |
2004-04-15 |
Devries Peter J. |
Erythropoietin receptor binding antibodies
|
AU2003285874A1
(en)
|
2002-10-16 |
2004-05-04 |
Amgen Inc. |
HUMAN ANTI-IFN-Gamma NEUTRALIZING ANTIBODIES AS SELECTIVE IFN-Gamma PATHWAY INHIBITORS
|
US20040091961A1
(en)
|
2002-11-08 |
2004-05-13 |
Evans Glen A. |
Enhanced variants of erythropoietin and methods of use
|
DE60335915D1
(de)
|
2002-12-20 |
2011-03-10 |
Amgen Inc |
Myostatin hemmende bindungsstoffe
|
CA2518980A1
(fr)
|
2003-03-14 |
2004-09-30 |
Pharmacia Corporation |
Anticorps specifiques du recepteur d'igf-i pour le traitement de cancers
|
ATE549359T1
(de)
|
2003-04-02 |
2012-03-15 |
Hoffmann La Roche |
Antikörper gegen den insulinähnlichen wachstumsfaktor i-rezeptor und deren verwendungen
|
US7220410B2
(en)
|
2003-04-18 |
2007-05-22 |
Galaxy Biotech, Llc |
Monoclonal antibodies to hepatocyte growth factor
|
US7638605B2
(en)
|
2003-05-01 |
2009-12-29 |
ImClone, LLC |
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
WO2004101611A2
(fr)
|
2003-05-12 |
2004-11-25 |
Affymax, Inc. |
Nouveaux peptides se fixant au recepteur de l'erythropoietine
|
SI1629007T1
(sl)
|
2003-05-12 |
2009-10-31 |
Affymax Inc |
Novi peptidi, ki se veĹľejo na eritropoetinski receptor
|
EP1626983B8
(fr)
|
2003-05-12 |
2010-12-22 |
Affymax, Inc. |
Nouveaux composes modifies par du poly(ethylene glycol) et leurs utilisations
|
US7074755B2
(en)
|
2003-05-17 |
2006-07-11 |
Centocor, Inc. |
Erythropoietin conjugate compounds with extended half-lives
|
KR20060032140A
(ko)
|
2003-05-30 |
2006-04-14 |
센토코 인코포레이티드 |
트랜스글루타미나아제를 이용한 신규 에리트로포이에틴접합체의 형성
|
US20050037390A1
(en)
|
2003-06-04 |
2005-02-17 |
Irm Llc, A Delaware Limited Liability Company |
Methods and compositions for modulating erythropoietin expression
|
US7579157B2
(en)
|
2003-07-10 |
2009-08-25 |
Hoffmann-La Roche Inc. |
Antibody selection method against IGF-IR
|
WO2005019266A2
(fr)
|
2003-07-15 |
2005-03-03 |
Amgen Inc. |
Anticorps neutralisants anti-ngf humains utilises comme inhibiteurs selectifs de la voie de ngf
|
RS53476B
(en)
|
2003-07-18 |
2014-12-31 |
Amgen Fremont Inc. |
Hepatocyte Growth Factor Binders
|
US20050019914A1
(en)
|
2003-07-24 |
2005-01-27 |
Aventis Pharma Deutschland Gmbh |
Perfusion process for producing erythropoietin
|
GB0317511D0
(en)
|
2003-07-25 |
2003-08-27 |
Biovex Ltd |
Viral vectors
|
WO2005021579A2
(fr)
|
2003-08-28 |
2005-03-10 |
Biorexis Pharmaceutical Corporation |
Peptides mimetiques epo et proteines de fusion
|
AU2004316266A1
(en)
|
2003-09-30 |
2005-09-09 |
Centocor, Inc. |
Human hinge core mimetibodies, compositions, methods and uses
|
UA89481C2
(uk)
|
2003-09-30 |
2010-02-10 |
Центокор, Инк. |
Еритропоетинові міметичні шарнірно-серцевинні міметитіла людини, композиції, способи та застосування
|
US7638606B2
(en)
|
2003-11-07 |
2009-12-29 |
Immunex Corporation |
Antibodies that bind interleukin-4 receptor
|
TW200526684A
(en)
|
2003-11-21 |
2005-08-16 |
Schering Corp |
Anti-IGFR1 antibody therapeutic combinations
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
CA2547140A1
(fr)
|
2003-11-24 |
2005-06-09 |
Neose Technologies, Inc. |
Erythropoietine glycopegylee
|
WO2005058967A2
(fr)
|
2003-12-16 |
2005-06-30 |
Pierre Fabre Medicament |
Nouveau recepteur hybride anti-insuline/igf-i ou recepteur hybride anti-insuline/igf-i et anticorps igf-ir et applications
|
EP1548031A1
(fr)
|
2003-12-22 |
2005-06-29 |
Dubai Genetics FZ-LLC |
Erythropoietin identique à la nature
|
BRPI0417916A
(pt)
|
2003-12-31 |
2007-04-10 |
Merck Patent Gmbh |
proteìna de fusão de fc-eritropoietina com farmacocinética melhorada
|
CA2551131A1
(fr)
|
2003-12-31 |
2005-07-21 |
Centocor, Inc. |
Nouvelles proteines recombinees avec thiol libre n-terminal
|
US7423139B2
(en)
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
US20050187158A1
(en)
|
2004-01-22 |
2005-08-25 |
Ranby Mats G. |
Pharmaceutical composition
|
WO2005084711A1
(fr)
|
2004-03-02 |
2005-09-15 |
Chengdu Institute Of Biological Products |
Erythropoietine recombinante pegylee a activite in vivo
|
AR048918A1
(es)
|
2004-03-11 |
2006-06-14 |
Fresenius Kabi De Gmbh |
Conjugados de almidon de hidroxietilo y eritropoyetina
|
AU2005229009A1
(en)
|
2004-03-23 |
2005-10-13 |
Amgen, Inc. |
Monoclonal antibodies specific for human OX40L (CD 134L)
|
US20050227289A1
(en)
|
2004-04-09 |
2005-10-13 |
Reilly Edward B |
Antibodies to erythropoietin receptor and uses thereof
|
GB2413328A
(en)
|
2004-04-23 |
2005-10-26 |
Cambridge Antibody Tech |
Erythropoietin protein variants
|
ATE429444T1
(de)
|
2004-07-07 |
2009-05-15 |
Lundbeck & Co As H |
Neues carbamyliertes epo und verfahren zu dessen herstellung
|
FR2873699B1
(fr)
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
WO2006029094A2
(fr)
|
2004-09-02 |
2006-03-16 |
Xencor, Inc. |
Derives d'erythropoietine a antigenicite modifiee
|
WO2006050959A2
(fr)
|
2004-11-10 |
2006-05-18 |
Aplagen Gmbh |
Molecules favorisant l'hematopoiese
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
AU2006208226A1
(en)
|
2005-01-24 |
2006-08-03 |
Amgen Inc. |
Humanized anti-amyloid antibody
|
US7592429B2
(en)
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
CA2612449A1
(fr)
|
2005-06-17 |
2006-12-28 |
Imclone Systems Incorporated |
Antagonistes de recepteur pour le traitement de cancer osseux metastatique
|
WO2007000328A1
(fr)
|
2005-06-27 |
2007-01-04 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Anticorps se fixant à un épitope sur un récepteur de facteur de croissance insulinomimétique de type 1 et leurs utilisations
|
EP1915398B1
(fr)
|
2005-07-18 |
2016-04-20 |
Amgen Inc. |
Anticorps neutralisants anti-b7rp1 humains
|
FR2888850B1
(fr)
|
2005-07-22 |
2013-01-11 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
PE20071101A1
(es)
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
GB0603683D0
(en)
|
2006-02-23 |
2006-04-05 |
Novartis Ag |
Organic compounds
|
CN100484584C
(zh)
*
|
2006-03-03 |
2009-05-06 |
杨运泰 |
吸杯无针注射器
|
TWI395754B
(zh)
|
2006-04-24 |
2013-05-11 |
Amgen Inc |
人類化之c-kit抗體
|
RU2008150314A
(ru)
|
2006-05-19 |
2010-06-27 |
Гликофи, Инк. (Us) |
Композиции эритропоэтина
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
EP2083859A4
(fr)
|
2006-11-07 |
2010-11-24 |
Merck Sharp & Dohme |
Antagonistes de pcsk9
|
JP5588175B2
(ja)
|
2006-11-07 |
2014-09-10 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Pcsk9のアンタゴニスト
|
EP2083860A4
(fr)
|
2006-11-07 |
2010-05-26 |
Merck Sharp & Dohme |
Antagonistes de pcsk9
|
WO2008133647A2
(fr)
|
2006-11-07 |
2008-11-06 |
Merck & Co., Inc. |
Antagonistes de pcsk9
|
CN101605814B
(zh)
|
2006-12-14 |
2014-02-19 |
默沙东公司 |
经工程改造的抗tslp抗体
|
CN101679527A
(zh)
|
2007-04-13 |
2010-03-24 |
诺瓦提斯公司 |
用于调节前蛋白转化酶枯草杆菌蛋白酶/kexin9型(pcsk9)的分子和方法
|
KR20100034015A
(ko)
|
2007-06-20 |
2010-03-31 |
아이알엠 엘엘씨 |
알레르기 질환 치료를 위한 방법 및 조성물
|
US7982016B2
(en)
|
2007-09-10 |
2011-07-19 |
Amgen Inc. |
Antigen binding proteins capable of binding thymic stromal lymphopoietin
|
JP2011501952A
(ja)
|
2007-10-26 |
2011-01-20 |
シェーリング コーポレイション |
脂質障害およびコレステロール障害を治療するための抗pcsk9および方法
|
AR070316A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Antagonistas de pcsk9 (proproteina subtilisina-kexina tipo 9)
|
AR070315A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Anticuerpos 1b20 antagonistas de pcsk9
|
TWI445716B
(zh)
|
2008-09-12 |
2014-07-21 |
Rinat Neuroscience Corp |
Pcsk9拮抗劑類
|
JO3672B1
(ar)
|
2008-12-15 |
2020-08-27 |
Regeneron Pharma |
أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
|
JO3382B1
(ar)
|
2008-12-23 |
2019-03-13 |
Amgen Inc |
أجسام مضادة ترتبط مع مستقبل cgrp بشري
|
WO2011037791A1
(fr)
|
2009-09-25 |
2011-03-31 |
Merck Sharp & Dohme Corp. |
Antagonistes de pcsk9
|
CN102639150A
(zh)
|
2009-10-30 |
2012-08-15 |
默沙东公司 |
Ax213和ax132 pcsk9拮抗剂和变体
|
AU2010313381A1
(en)
|
2009-10-30 |
2012-04-12 |
Merck Sharp & Dohme Corp. |
AX1 and AX189 PCSK9 antagonists and variants
|
AR079336A1
(es)
|
2009-12-11 |
2012-01-18 |
Irm Llc |
Antagonistas de la pro-proteina convertasa-subtilisina/quexina tipo 9 (pcsk9)
|
SG183867A1
(en)
|
2010-03-11 |
2012-10-30 |
Rinat Neuroscience Corp |
ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING
|
WO2012054438A1
(fr)
|
2010-10-22 |
2012-04-26 |
Schering Corporation |
Anti-pcsk9
|
SG191219A1
(en)
|
2010-12-22 |
2013-07-31 |
Genentech Inc |
Anti-pcsk9 antibodies and methods of use
|
AR084938A1
(es)
|
2011-01-28 |
2013-07-10 |
Sanofi Sa |
Anticuerpos humanos contra la proproteina convertasa subtilisina/kexina tipo 9 (anti pcsk9) para usar en metodos para tratar grupos de pacientes
|
MX2013009258A
(es)
|
2011-02-11 |
2013-10-17 |
Novartis Ag |
Antagonistas de pcsk9.
|
JOP20200043A1
(ar)
|
2011-05-10 |
2017-06-16 |
Amgen Inc |
طرق معالجة أو منع الاضطرابات المختصة بالكوليسترول
|
CN104755119B
(zh)
*
|
2012-10-19 |
2020-03-13 |
安进公司 |
改进的自动注射器
|
JP6426107B2
(ja)
|
2012-12-20 |
2018-11-21 |
アムジエン・インコーポレーテツド |
Apj受容体アゴニストおよびその使用
|
US20140274874A1
(en)
|
2013-03-14 |
2014-09-18 |
Amgen Inc. |
Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods
|
AP2015008729A0
(en)
|
2013-03-14 |
2015-09-30 |
Amgen Inc |
Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods
|
US20160250470A1
(en)
*
|
2015-02-26 |
2016-09-01 |
Stryker Corporation |
Rehabilitation Monitor And Pain Treatment Assembly
|
EP3386571B1
(fr)
*
|
2015-12-08 |
2024-04-03 |
Becton Dickinson France |
Capuchon en t pour injecteur médical
|
EP3532127A1
(fr)
*
|
2016-10-25 |
2019-09-04 |
Amgen Inc. |
Injecteur porté sur le corps
|